| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT06512428 A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma |
overall status: Recruiting → Unknown |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06656091 | A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal… | Advanced Oesophageal Squamous Cell Carcinoma | Not Yet Recruiting |
| NCT07613450 | A Phase III Study of SYHA1813 for Recurrent or Progressive High-Grade Meningiomas | High Grade Meningioma | Not Yet Recruiting |
| Phase 2 | |||
| NCT06739213 | A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma | Recurrent or Progressive High Grade Meningioma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06132217 | A Study of Simmitinib Plus SG001 in Advanced Solid Tumors | Advanced Solid Tumor | Not Yet Recruiting |
| NCT06577376 | A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric… | Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma | Not Yet Recruiting |
| NCT06682611 | Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in… | Unresectable Locally Advanced or Metastatic Solid Tumors | Not Yet Recruiting |